FREERIDE STUDY, Freeway Paclitaxel Coated Balloon Catheter to Treat Peripheral Artery Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.

Also called NCT01960647

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 280 participants (planned count) (from the registry)
Sponsor
Eurocor GmbH (from the registry)
Registry
  • NCT NCT01960647
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Austria, Colombia, Germany, Hungary, Italy, Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01960647. Randomized; no masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2014-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
FREERIDE STUDY, Freeway Paclitaxel Coated Balloon Catheter to Treat Peripheral Artery Disease
Condition
Peripheral Artery Disease
Intervention (Device)
Percutaneous transluminal angioplasty with uncoated balloon
Intervention (Device)
Percutaneous transluminal angioplasty with Paclitaxel balloon
Lead sponsor
Eurocor GmbH (class: industry)

Record details

Record id
cardio:ct-nct01960647
Content hash
73f7294c0c67c20a8de858adc70ee7db825fc1941351f4a6913d9e03b9422e7c